Harada Y - Search Results

1

Successful Cord Blood Transplantation for Idiopathic CD4+ Lymphocytopenia.

Yamamoto K, Najima Y, Iizuka H, Harada Y, Sadato D, Kanai A, Matsui H, Inamoto K, Mukae J, Shingai N, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K, Harada H, Doki N. Yamamoto K, et al. Among authors: harada h, harada y. Acta Haematol. 2021;144(6):698-705. doi: 10.1159/000516347. Epub 2021 Jun 1. Acta Haematol. 2021. PMID: 34062545

2

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.

Harada H, Harada Y, Tanaka H, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2003 Jan 15;101(2):673-80. doi: 10.1182/blood-2002-04-1010. Epub 2002 Sep 5. Blood. 2003. PMID: 12393679 Free article.

3

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2004 Mar 15;103(6):2316-24. doi: 10.1182/blood-2003-09-3074. Epub 2003 Nov 13. Blood. 2004. PMID: 14615365 Free article.

4

Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.

Harada H, Harada Y. Harada H, et al. Among authors: harada y. Crit Rev Eukaryot Gene Expr. 2005;15(3):183-96. doi: 10.1615/critreveukargeneexpr.v15.i3.10. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16390315 Review.

5

Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.

Harada H, Harada Y, Kimura A. Harada H, et al. Among authors: harada y. Curr Cancer Drug Targets. 2006 Sep;6(6):553-65. doi: 10.2174/156800906778194595. Curr Cancer Drug Targets. 2006. PMID: 17017876 Review.

6

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.

Harada Y, Harada H. Harada Y, et al. Among authors: harada h. J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. J Cell Physiol. 2009. PMID: 19334039 Review.

7

AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.

Ding Y, Harada Y, Imagawa J, Kimura A, Harada H. Ding Y, et al. Among authors: harada h, harada y. Blood. 2009 Dec 10;114(25):5201-5. doi: 10.1182/blood-2009-06-223982. Blood. 2009. PMID: 19850737 Free article.

8

[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes].

Harada H, Harada Y, Kimura A. Harada H, et al. Among authors: harada y. Nihon Rinsho. 2009 Oct;67(10):1901-5. Nihon Rinsho. 2009. PMID: 19860187 Review. Japanese.

9

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia.

Imagawa J, Harada Y, Shimomura T, Tanaka H, Okikawa Y, Hyodo H, Kimura A, Harada H. Imagawa J, et al. Among authors: harada h, harada y. Blood. 2010 Dec 23;116(26):6018-22. doi: 10.1182/blood-2010-06-289389. Epub 2010 Sep 22. Blood. 2010. PMID: 20861459 Free article.

10

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.

Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K, Nakahara F, Oki T, Enomoto Y, Fukuchi Y, Nakajima H, Harada Y, Harada H, Kitamura T. Kato N, et al. Among authors: harada h, harada y. Blood. 2011 Jan 6;117(1):221-33. doi: 10.1182/blood-2010-02-270181. Epub 2010 Sep 30. Blood. 2011. PMID: 20884804 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,764 results

Search Page